Increased TFRC expression was linked to decreased overall survival (OS) (p = 0.024), disease-specific survival (DSS) (p = 0.009), and progression-free interval (PFI) (p = 0.007) in CESC patients. This evidence concerns the gene TFRC and cervical squamous cell carcinoma.